Congenital adrenal hyperplasia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 44: | Line 44: | ||
==Treatment== | ==Treatment== | ||
[[Congenital adrenal hyperplasia medical therapy| Medical Therapy]] | [[Congenital adrenal hyperplasia surgery|Surgery]] | [[Congenital adrenal hyperplasia primary prevention|Primary Prevention]] | [[Congenital adrenal hyperplasia secondary prevention|Secondary prevention]] | |||
==Case Studies== | ==Case Studies== | ||
Revision as of 20:35, 24 August 2012
For patient information click here
| Congenital adrenal hyperplasia | |
 | |
|---|---|
| Cortisol | |
| ICD-10 | E25.0 |
| ICD-9 | 255.2 |
| OMIM | 201910 201710 202110 201810 202010 |
| DiseasesDB | 1854 Template:DiseasesDB2 Template:DiseasesDB2 Template:DiseasesDB2 Template:DiseasesDB2 |
| MedlinePlus | 000411 |
| MeSH | D000312 |
|
Congenital adrenal hyperplasia main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Congenital Adrenal Hyperplasia from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary prevention
Case Studies
See also